Michela Mauri
About Michela Mauri
Michela Mauri serves as the Customer Success Director EMEA at SOPHiA GENETICS, bringing extensive experience in oncology and cancer research. She has held various roles within the company since 2019 and has a strong sales background in the biotechnology industry.
Current Role at SOPHiA GENETICS
Michela Mauri currently serves as the Customer Success Director EMEA at SOPHiA GENETICS, a position she has held since 2023. In this role, she focuses on enhancing customer satisfaction and ensuring the successful implementation of the company's genomic analysis solutions across the EMEA region.
Previous Positions at SOPHiA GENETICS
Michela Mauri has held several key positions at SOPHiA GENETICS. She worked as a Regional Sales Manager for South Eastern Europe from 2019 to 2021, and as a Regional Sales Director from 2021 to 2023. Additionally, she served as a Subject Matter Expert Manager for 11 months in 2019 and as a Sales and Business Development Manager from 2016 to 2019.
Experience at Agilent Technologies
Prior to her tenure at SOPHiA GENETICS, Michela Mauri worked at Agilent Technologies. She served as an Inside Sales Representative and Account Manager for Sicily and Sardinia from 2013 to 2016. Additionally, she completed a Marketing Internship at Agilent Technologies from 2012 to 2013.
Educational Background in Biotechnology
Michela Mauri studied at Università degli Studi di Milano, where she earned a Master's degree in Biotechnology and Molecular Medicine from 2010 to 2012. She also obtained a degree in Medical Biotechnology from the same university, studying from 2007 to 2010. Her academic background provides a strong foundation for her work in the biotechnology industry.
Internship Experience in Oncology
Michela Mauri has gained valuable experience through various internships. She completed an internship at the IRCCS Istituto Nazionale dei Tumori Foundation in Milan from 2011 to 2012, focusing on cancer research. Additionally, she interned at the Università degli Studi di Milano in the Department of Public Health, Microbiology, and Virology in 2010.